NantOmics hopes to enhance its diagnostics platform with the addition of Genos' sequencing technology and expertise.
The company allows individuals to have their exomes sequenced from a saliva sample and share the data with researchers in exchange for compensation.
The exome-sequencing consumer genomics startup has added George Church and Dietrich Stephan to its advisory board, along with several others.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.